Mease, P. J., Young, P., Fallon, L., Mundayat, R., Dina, O., Blachley, T., . . . Ogdie, A. (2024). Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry. Rheumatology & Therapy, 11(2), 313. https://doi.org/10.1007/s40744-023-00631-4
Chicago Style (17th ed.) CitationMease, Philip J., Pamela Young, Lara Fallon, Rajiv Mundayat, Oluwaseyi Dina, Taylor Blachley, Nicole Middaugh, and Alexis Ogdie. "Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry." Rheumatology & Therapy 11, no. 2 (2024): 313. https://doi.org/10.1007/s40744-023-00631-4.
MLA (9th ed.) CitationMease, Philip J., et al. "Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry." Rheumatology & Therapy, vol. 11, no. 2, 2024, p. 313, https://doi.org/10.1007/s40744-023-00631-4.